Your browser doesn't support javascript.
loading
Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma.
Pires da Silva, Inês; Ahmed, Tasnia; McQuade, Jennifer L; Nebhan, Caroline A; Park, John J; Versluis, Judith M; Serra-Bellver, Patricio; Khan, Yasir; Slattery, Tim; Oberoi, Honey K; Ugurel, Selma; Haydu, Lauren E; Herbst, Rudolf; Utikal, Jochen; Pföhler, Claudia; Terheyden, Patrick; Weichenthal, Michael; Gutzmer, Ralf; Mohr, Peter; Rai, Rajat; Smith, Jessica L; Scolyer, Richard A; Arance, Ana M; Pickering, Lisa; Larkin, James; Lorigan, Paul; Blank, Christian U; Schadendorf, Dirk; Davies, Michael A; Carlino, Matteo S; Johnson, Douglas B; Long, Georgina V; Lo, Serigne N; Menzies, Alexander M.
Afiliação
  • Pires da Silva I; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
  • Ahmed T; Charles Perkins Centre, The University of Sydney, Sydney, Australia.
  • McQuade JL; Westmead and Blacktown Hospitals, Sydney, Australia.
  • Nebhan CA; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
  • Park JJ; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Versluis JM; Vanderbilt University Medical Center, Nashville, TN.
  • Serra-Bellver P; Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.
  • Khan Y; Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Slattery T; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Oberoi HK; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Ugurel S; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Haydu LE; Hospital Clinic, Barcelona & IDIBAPS, Barcelona, Spain.
  • Herbst R; University Hospital Essen, University of Duisburg-Essen, German Cancer Consortium, Partner Site Essen, Essen, Germany.
  • Utikal J; Westmead and Blacktown Hospitals, Sydney, Australia.
  • Pföhler C; Helios Klinikum Erfurt, Erfurt, Germany.
  • Terheyden P; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Weichenthal M; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
  • Gutzmer R; Saarland University Medical Center, Homburg/Saar, Germany.
  • Mohr P; Department of Dermatology, University of Lübeck, Lübeck, Germany.
  • Rai R; University Skin Cancer Center Kiel, University Hospital of Schleswig-Holstein, Kiel, Germany.
  • Smith JL; Skin Cancer Center, Department of Dermatology, Mühlenkreiskliniken, Ruhr University Bochum Campus Minden, Minden, Germany.
  • Scolyer RA; Elbe-Klinikum Buxtehude, Buxtehude, Germany.
  • Arance AM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
  • Pickering L; Westmead and Blacktown Hospitals, Sydney, Australia.
  • Larkin J; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
  • Lorigan P; Charles Perkins Centre, The University of Sydney, Sydney, Australia.
  • Blank CU; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, Australia.
  • Schadendorf D; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Davies MA; Hospital Clinic, Barcelona & IDIBAPS, Barcelona, Spain.
  • Carlino MS; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Johnson DB; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Long GV; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Lo SN; Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
  • Menzies AM; Netherlands Cancer Institute, Amsterdam, the Netherlands.
J Clin Oncol ; 40(10): 1068-1080, 2022 04 01.
Article em En | MEDLINE | ID: mdl-35143285
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Segunda Neoplasia Primária / Neoplasias Pulmonares / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Segunda Neoplasia Primária / Neoplasias Pulmonares / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália